Journal articleClin Cancer Res2020

Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer.

DOI 10.1158/1078-0432.ccr-19-2926 ↗ OpenAlex, retrieved 5 November 2026

Journal: Clin Cancer Res
Published: 18 October 2019
Citations: 44
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Grants 5

Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798 ↗
Tissue Core P50CA127297 ↗
Targeting Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer R01CA163649 ↗
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer R01CA210439 ↗
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer R01CA216853 ↗